Showing results (11-20 of 140) with videos related to
Sort By:
Pageof 14
Current Pharmaceutical Design|November 17, 2004
Advanced glycation and advanced lipoxidation: possible role in initiation and progression of diabetic retinopathyAlan W Stitt, Norma Frizzell, Suzanne R ThorpeVision Research|April 17, 2017
The pathology associated with diabetic retinopathyJudith Lechner, Olivia E O'Leary, Alan W StittMolecular Vision|July 6, 2004
Ocular wounding prevents pre-retinal neovascularization and upregulates PEDF expression in the inner retinaAlan W Stitt, Donna Graham, Tom A GardinerStem Cell Research & Therapy|December 14, 2011
Eyes open to stem cells: safety trial may pave the way for cell therapy to treat retinal disease in patientsReinhold J Medina, Desmond B Archer, Alan W StittInvestigative Ophthalmology & Visual Science|December 10, 2017
Animal Models of Retinal Vein OcclusionMeiaad Khayat, Noemi Lois, Michael Williams, et al.European Biophysics Journal : EBJ|June 23, 2021
A novel assay based on pre-equilibrium titration curves for the determination of enzyme inhibitor binding kineticsBernard Noppen, Anouk Vanbelle, Alan W Stitt, et al.Nature Reviews. Endocrinology|January 20, 2021
Current understanding of the molecular and cellular pathology of diabetic retinopathyDavid A Antonetti, Paolo S Silva, Alan W StittExpert Opinion on Investigational Drugs|September 13, 2002
Advanced glycation end products and diabetic complicationsAlan W Stitt, Alicia J Jenkins, Mark E CooperJCI Insight|July 21, 2017
Diabetic retinopathy: current understanding, mechanisms, and treatment strategiesElia J Duh, Jennifer K Sun, Alan W StittMethods in Molecular Biology (Clifton, N.J.)|January 9, 2013
Raman spectroscopy for the detection of AGEs/ALEsJ Renwick Beattie, John J McGarvey, Alan W StittPageof 14